Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin add-on to interferon beta-1a in relapsing-remitting multiple sclerosis
2005-003930-16Phase 4Completed
- Sponsor
- Biogen
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in multiple sclerosis (MS) comparing Interferon beta-1a + simvastatin with Interferon beta-1a + placebo (2 arms). Primary endpoint: Time to first documented relapse. Started Nov 2005; status: completed.
02
Drugs
simvastatin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-003930-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003930-16.